Abstract:Hepatocellular carcinoma (HCC) is a lethal malignancy. Although considerable efforts have been made in recent years regarding treatments, effective therapeutic drugs for HCC remain insufficient. In the present study, polyphyllin VI was identified as a potential therapeutic drug for HCC by screening natural herbal compounds. The therapeutic effects of polyphyllin VI were assessed using Cell Counting Kit‑8, lactate dehydrogenase release and colony formation assays. The occurrence of ferroptosis was determined by assessing lipid peroxidation by reactive oxygen species, malondialdehyde levels, intracellular ferrous iron levels, and the mRNA and protein levels of glutathione peroxidase 4 (GPX4). The migratory and invasive abilities of HCC cells were examined using wound healing and Transwell assays. The results revealed that polyphyllin VI inhibited the proliferation, invasion and metastasis of HCC cells (HCCLM3 and Huh7 cells) by inducing ferroptosis. In addition, through a network pharmacology‑based approach and molecular docking analyses, it was found that polyphyllin VI may target the signal transducer and activator of transcription 3 (STAT3). HCC cells were treated with polyphyllin VI or a STAT3 inhibitor (Stattic), both of which exerted similar inhibitory effects on protein expression. Furthermore, immunofluorescence staining revealed that polyphyllin VI significantly inhibited the nuclear translocation of p‑STAT3 in HCC cells. Mechanistically, by the overexpression of STAT3, it was confirmed that STAT3 binds to GPX4 and promotes its protein expression and transcription, whereas polyphyllin VI induces ferroptosis by inhibiting the STAT3/GPX4 axis. Subsequently, in vivo experiments revealed that polyphyllin VI inhibited the growth of subcutaneously transplanted tumors. On the whole, findings of the present study suggest that polyphyllin VI inhibits STAT3 phosphorylation, which inhibits GPX4 expression and induces the ferroptosis of HCC cells, eventually inhibiting their invasion and metastasis. These data suggest that polyphyllin VI may be a candidate for the prevention and treatment of HCC.

Antiproliferative Activity and Therapeutic Implications of Potassium Tris(4-Methyl-1-pyrazolyl) Borohydride in Hepatocellular Carcinoma

In vitro and in vivo study of BZG-4000: Anti-tumoral activity of human hepatocellular carcinoma

The Aryl Hydrocarbon Receptor Ligand ITE Inhibits Cell Proliferation and Migration and Enhances Sensitivity to Drug-Resistance in Hepatocellular Carcinoma.

Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies.

Inhibitory effect of protonic bis(5-amino-1,10-phenanthroline) on proliferation of hepatocellular carcinoma and its molecular mechanism

Growth Inhibition of a Novel Iron Chelator, DpdtC, Against Hepatoma Carcinoma Cell Lines Partly Attributed to Ferritinophagy-Mediated Lysosomal ROS Generation

Potassium Iodide Enhances the Anti-Hepatocellular Carcinoma Effect of Copper-Cysteamine Nanoparticle Mediated Photodynamic Therapy on Cancer Treatment

Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.

Combined Levo-tetrahydropalmatine and diphenyleneiodonium chloride enhances antitumor activity in hepatocellular carcinoma

Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma.

Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves Fenton-Derived Free Radical Generation

Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment

Design, synthesis and biological evaluation of 5H-[1,2,4]triazino[5,6-b]indole derivatives bearing a pyridinocycloalkyl moiety as iron chelators

Preparation of kakkatin derivatives and their anti-tumor activity

High‑throughput screening identification of a small‑molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis

Combating liver cancer through GO-targeted biomaterials

Ferroptosis: a New Promising Target for Hepatocellular Carcinoma Therapy

Ph-Sensitive Nanoformulated Triptolide As a Targeted Therapeutic Strategy for Hepatocellular Carcinoma.

Novel Mitochondrion-Targeting Copper(ii) Complex Induces HK2 Malfunction and Inhibits Glycolysis Via Drp1-mediating Mitophagy in HCC

The Antitumor Mechanism of Di-2-Pyridylketone 2-Pyridine Carboxylic Acid Hydrazone and Its Copper Complex in Ros Generation and Topoisomerase Inhibition, and Hydrazone Involvement in Oxygen-Catalytic Iron Mobilization

Synthesis, Toxicity and Antitumor Activity of Cobalt Carbonyl Complexes Targeting Hepatocellular Carcinoma.